IL1B and ocular melanoma: Furthermore, treatment with an IL1β‐neutralizing antibody, despite the retention of some IL1β‐positive or senescent cells, led to a marked reduction in SF1‐HP cells, suggesting that secreted IL1β may contribute to the high expression of SF1 in the adrenocortical cells of OM.